Glaxo drug shown to delay ovarian cancer relapse

By Deena Beasley

CHICAGO | Sat Jun 1, 2013 7:31am EDT

CHICAGO (Reuters) – A cancer drug sold by GlaxoSmithKline was shown in a clinical trial to extend survival by several months for ovarian cancer patients whose disease had returned after initial surgery and chemotherapy.

The findings suggest that the oral drug, Votrient, could be used as a “maintenance” therapy for many ovarian cancer patients.

Dutch authorities to cull poultry after avian influenza outbreak

AMSTERDAM | Sat Jun 1, 2013 8:20am EDT

AMSTERDAM (Reuters) – Health authorities will cull 11,000 chickens at a farm in the Netherlands after an outbreak of a mild form of avian influenza, the Dutch Economic Affairs Ministry said on Saturday.

The chickens were believed to have the low pathogenic H7 strain, the ministry said in a statement. They would be culled as a precaution because the strain can mutate into a form that is fatal for poultry.

Authorities imposed a one-kilometer safety perimeter around the farm banning transports of poultry, eggs and other farm products. Testing would also be carried at 11 other farms in the area, it said.